Hepatitis C virus (HCV) sequences were detected in cerebrospinal fluid (CSF) in 8 of 13 HCV-positive patients. In four patients harboring different virus strains in serum and peripheral blood mononuclear cells (PBMC), CSF-derived virus was similar to that found in PBMC, which suggests that PBMC could carry HCV into the brain.
Hepatitis C virus (HCV) sequences were detected in cerebrospinal fluid (CSF) in 8 of 13 HCV-positive patients. In four patients harboring different virus strains in serum and peripheral blood mononuclear cells (PBMC), CSF-derived virus was similar to that found in PBMC, which suggests that PBMC could carry HCV into the brain.
Patients with chronic hepatitis C are likely to have significant changes in their physical and mental well-being, most commonly manifested as fatigue and depression (5, 19) , and hepatitis C virus (HCV) itself could affect cerebral function (4) . Direct infection of the central nervous system (CNS) by HCV seems likely. HCV belongs to the family Flaviviridae, which includes well-known neurotropic viruses (e.g., yellow fever, dengue, and tick-borne encephalitis viruses), and in a recent study, we detected HCV RNA negative strand, which is a viral replicative intermediate, in brain tissue in HCV-infected patients (17) . However, how HCV enters the CNS remains unclear. The present study was undertaken to determine whether circulating leukocytes could carry HCV into the CNS.
Thirteen patients who were anti-HCV positive and who underwent nontraumatic lumbar puncture for diagnostic purposes were studied. Clinical and laboratory data from these patients are presented in Table 1 . Serum, peripheral blood mononuclear cells (PBMC), and cerebrospinal fluid (CSF) samples were collected on the same day and stored frozen at Ϫ80°C. RNAs were extracted from the whole CSF cell pellet or 5 ϫ 10 6 to 1 ϫ 10 7 PBMC by using a commercially available kit (Trizol; Gibco BRL) and were amplified by reverse transcription-PCR (RT-PCR) as described previously (11) .
Strand-specific RT-PCR. The strand specificity of our RT-PCR was ascertained by conducting cDNA synthesis at high temperature with the thermostable enzyme Tth. A detailed description of the assay was published previously (12) . The assay was capable of detecting approximately 100 genomic eq molecules of the correct strand while unspecifically detecting Ն10 8 genomic eq of the incorrect strand. To determine its performance with samples containing replicating virus, we tested serial dilutions of RNA extracted from liver tissue samples from chronically infected patients. HCV RNA negative strand was detected in all three livers analyzed at a titer 1 to 2 logs lower than that of the positive strand (Fig. 1A) .
Analysis of HCV sequences. The analysis was conducted with the 5Ј untranslated region (5ЈUTR), because a small number of expected viral variants within quasispecies allows for reliable comparison, and we have previously found that variations in this region may correlate with extrahepatic replication (10, 11) . Nested protocols were used to maximize the yield of PCR product, and HCV quasispecies were compared by the singlestrand conformation polymorphism (SSCP) assay as described elsewhere (11) . The products analyzed were sequenced directly in both directions with a Perkin-Elmer ABI 377 automatic sequencer. The HCV genotypes were determined by sequencing the NS5b region (13) .
HCV RNA was found in all sera and in 12 PBMC samples (Table 1) . When CSF samples were analyzed, HCV RNA was detected in 8 of 13 cellular pellets and in 2 supernatants. The HCV RNA negative strand was not detected in any of the sera analyzed; however, it was detected in two PBMC samples and two CSF cell pellets. These reactions were unlikely to represent false-positive results, because nonspecific detection of the incorrect strand might be expected when the latter is present at a high number: at least 10 8 genomic eq/reaction. However, the concentration of HCV RNA in samples containing viral negative strand was no more than 10 3 genomic eq/reaction (Fig.  1A) . Patients in whom HCV RNA could not be amplified from CSF were excluded from subsequent analysis.
Next, viral sequences amplified from CSF were compared by SSCP with respective viral sequences amplified from serum and PBMC. As seen in Fig. 1B , only in patient 8 were the band patterns of viral sequences amplified from serum, PBMC, and CSF identical. In patients 4 and 7, the serum patterns were identical to those of PBMC, while there were fewer CSF bands. However, the dominant SSCP bands were identical in all samples from each of these two patients.
In the remaining five patients (subjects 1 to 3, 10, and 12), viral sequences recovered from CSF were different from those derived from serum. Importantly, in patients 1, 2, 10, and 12, PBMC-derived HCV band patterns were also different from serum sequences.
Direct sequencing confirmed the presence of identical 5ЈUTR consensus sequences in serum, PBMC, and CSF in patients 4, 7, and 8. In patient 3, "master" sequences amplified from CSF differed by 1 nucleotide substitution from serum and PBMC sequences, but the difference was more substantial in the NS5 region (14 substitutions in the 226-nucleotide-length fragment [data not shown]). In patients 1 and 2, sequences recovered from CSF cells were classified as belonging to a different genotype from those found in serum. However, the latter were of the same genotype as sequences amplified from PBMC (Table 1 ). These differences in viral genotypes between serum, PBMC, and, CSF were confirmed by sequencing of the NS5b region.
To better study the HCV sequences in patients 1 and 2, the respective amplicons were cloned (Invitrogen TA cloning system). All 44 clones derived from serum of patient 1 harbored closely related type 3a sequences (Fig. 2) . However, 87 and 88% of clones derived from PBMC and CSF, respectively, harbored a different sequence, which was classified as type 1a.
In patient 2, all serum-derived clones contained identical type 1a viral sequence, while PBMC-and CSF-derived clones harbored a number of closely related sequences that were different from those found in serum. These sequences were classified as belonging to genotype 4c (15) .
In patient 12, direct sequencing of the 5ЈUTR revealed the presence of slightly different sequences in the serum, PBMC, and CSF compartments. Although these differences were too subtle to determine the origin of the virus present in CSF, analysis of the NS5 region was more conclusive, because PBMC-and CSF-derived sequences shared five unique substitutions compared to the serum virus (data not shown). Also in patient 10, 5ЈUTR sequences amplified from CSF seemed to be more closely related to the PBMC viral fraction than to the virus circulating in serum (Fig. 2) . All basic groups of leukocytes-T cells, B cells, macrophages/monocytes, and NK cells-have the ability to enter the brain under certain conditions (6) . Certain monocyte family members are constantly being replaced as part of normal physiology (8, 20) , while the entry of T cells and B cells appears dependent only on the activation state of the leukocyte and not on CNS factors (7, 9) . Since HCV can replicate in leukocytes (1, 10, 11, 14, 18) , it might be expected that these cells could carry the virus into the CNS. Our study supports this conjecture, because the presence of HCV RNA was found in the CSF cellular pellet in 8 of 13 patients studied. Moreover, HCV replicative forms were detected in two of these samples, providing direct evidence that the virus associated with CSF cells may be actively replicating and not just passively adsorbed. The lymphoid origin of HCV in CSF is supported by the findings that in four patients in whom PBMC-and serum-derived viral sequences were different, the HCV RNA found in CSF was closely related to the former, but dissimilar from the latter. Thus, HCV neuroinvasion could be related to trafficking of infected leukocytes through the blood-brain barrier, in a process similar to that postulated for human immunodeficiency virus type 1 (HIV-1) infection (16, 21) . Subsequently, there could be a secondary spread of HCV to permissive cells within the brain. The most likely target would be the brain microglial cells, which are essentially tissue-resident macrophages of blood monocytic origin (3). Interestingly, in patients 1, 2, 10, and 12, SSCP and sequencing analysis revealed that CSF-derived viral sequences contained a number of variants that were present neither in serum nor in PBMC. This suggests an independent viral evolution in the cells present in CSF and is an argument for the presence of an independent viral compartment in the CNS.
In summary, we documented the presence of HCV in CSF of infected patients. The virus was associated with CSF cells, and in patients harboring different viral strains in serum and PBMC, it was more closely related to PBMC-than serumderived virus, which suggests that HCV-infected leukocytes carry the virus into the CNS. 
